American Board of Internal Medicine (ABIM) Certification Practice Exam 2025 - Free ABIM Practice Questions and Study Guide

Question: 1 / 2705

Which medication is FDA approved for treating irritable bowel syndrome with constipation?

Metoclopramide

Linaclotide

Linaclotide is FDA approved for treating irritable bowel syndrome with constipation (IBS-C). It is a guanylate cyclase-C agonist that works by increasing fluid secretion in the intestine and accelerating intestinal transit. This medication is specifically indicated for patients suffering from IBS-C, providing relief from symptoms such as abdominal pain and constipation.

The other medications listed are not exclusively approved for IBS-C. Metoclopramide is primarily indicated for gastroesophageal reflux disease and delayed gastric emptying, but it does not specifically target the symptoms of IBS-C. Bisacodyl and Senna are stimulant laxatives used for general constipation relief but are not FDA approved for the treatment of IBS-C, which requires a more targeted therapy to address both abdominal pain and constipation associated with the syndrome.

Thus, Linaclotide stands out as the specific treatment option intended for IBS-C, making it the appropriate choice in this context.

Get further explanation with Examzify DeepDiveBeta

Bisacodyl

Senna

Next Question

Report this question

Download American Board of Internal Medicine (ABIM) Certification Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy